Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A newly identified epigenetic modifier increases fetal hemoglobin in preclinical studies.

More information

DOI

10.1126/science.adq3757

Type

Journal article

Publication Date

05/07/2024

Volume

385

Pages

27 - 28

Total pages

1

Keywords

Animals, Humans, Mice, Anemia, Sickle Cell, Epigenesis, Genetic, Fetal Hemoglobin, Antisickling Agents, Drug Discovery